| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,568 |
15,545 |
$633K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,662 |
5,405 |
$399K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,798 |
2,691 |
$321K |
| 99406 |
|
10,982 |
10,664 |
$211K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,586 |
2,480 |
$138K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,183 |
2,071 |
$114K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,778 |
1,665 |
$93K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,555 |
1,466 |
$60K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,006 |
918 |
$55K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
482 |
457 |
$30K |
| 94760 |
|
1,642 |
1,592 |
$22K |
| 92550 |
|
566 |
556 |
$15K |
| 94010 |
|
276 |
274 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
750 |
722 |
$9K |
| D1206 |
Topical application of fluoride varnish |
360 |
351 |
$7K |
| 90670 |
|
592 |
584 |
$6K |
| 99188 |
|
351 |
330 |
$6K |
| 90698 |
|
374 |
371 |
$5K |
| 90633 |
|
300 |
294 |
$3K |
| 87631 |
|
19 |
18 |
$2K |
| 90710 |
|
208 |
205 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
20 |
19 |
$2K |
| 99381 |
|
38 |
38 |
$2K |
| 90734 |
|
142 |
138 |
$2K |
| 90651 |
|
132 |
131 |
$2K |
| 90744 |
|
124 |
121 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
95 |
66 |
$1K |
| 90672 |
|
107 |
107 |
$1K |
| 90680 |
|
99 |
99 |
$1K |
| 90715 |
|
87 |
85 |
$996.16 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
16 |
$723.68 |
| 90696 |
|
50 |
50 |
$610.46 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
105 |
99 |
$598.40 |
| 90677 |
|
26 |
26 |
$341.64 |
| 90697 |
|
14 |
14 |
$216.30 |
| 90688 |
|
12 |
12 |
$114.72 |